Raw Material Sampling
Raw material sampling is the GMP-controlled removal of representative aliquots from received containers for identity, conformance and any additional testing required by the material specification. Governed by 21 CFR 211.84, EU GMP Chapter 6, USP <1097> and ICH Q7 §7.30, it is the activity that converts received material from 'documented' to 'tested' — and the statistical foundation under every QA release decision.
01What raw material sampling is
Sampling is the deliberate, statistically defensible extraction of small portions from a received lot for laboratory testing. 21 CFR 211.84(a) requires that each lot of components be withheld from use until released by QC; 211.84(b)(2) requires that samples be representative; 211.84(b)(3) requires identity testing on each container with a scientifically sound sampling plan for other attributes. EU GMP Chapter 6 and USP <1097> add detail on plan design, sampling tools and contamination control.
- Performed under defined environmental conditions (cleanroom or sampling booth where required).
- Uses dedicated, qualified sampling tools (thieves, scoops) to avoid cross-contamination.
- Follows a written sampling plan with rationale documented in the material spec.
- Generates sample IDs derived from the parent lot ID for traceability.
- Sealed and labelled samples are transferred to QC with chain-of-custody.
02Sampling plan archetypes
| Plan | Rule | Use case |
|---|---|---|
| 100% identity | Every container sampled and identity-tested | APIs, excipients, high-risk materials (ICH Q7) |
| √n+1 | Square root of container count plus one, sampled for conformance | Lower-risk excipients, packaging components |
| n | Every container sampled | Critical materials with no supplier history |
| p | Statistically derived per ANSI/ASQ Z1.4 | AQL-based attribute sampling |
| Composite | Aliquots from N containers combined | Bulk powders for full conformance suite |
Plan selection is a documented risk decision per ICH Q9 — never a convenience. Mixing identity (per container) with conformance (composite or √n+1) is the norm.
03Contamination control during sampling
- Dedicated sampling area or booth with appropriate cleanroom grade for the material.
- Garment requirements aligned with the area grade and the material's product-contact status.
- Single-use or fully cleaned-and-qualified sampling tools per container.
- Sampling sequence designed to avoid carryover (e.g. low-potency → high-potency).
- Environmental monitoring during sampling for sterile or low-bioburden materials.
- Container reseal protocol — typically a tamper-evident reseal with sampler signature.
04Sampling documentation
- Sampling record — sampler ID, date/time, container IDs sampled, aliquot weights, environmental conditions.
- Sample IDs linked to parent lot ID — typically lot-NNNN-sNNN format.
- Chain of custody — every transfer between sampler, QC and archive stamped and signed.
- Retention sample drawn and stored per 21 CFR 211.170 (reserve samples).
- Deviation if plan cannot be executed as written.
05Common mistakes
- Skipping per-container identity in favour of √n+1 — direct violation of 211.84(b)(3) and ICH Q7 §7.30.
- Sampling plan undocumented in the spec — auditors cannot find the rationale.
- Sampling tools not qualified or cleaned — cross-contamination risk uncontrolled.
- Composite sample tested for identity — defeats the per-container intent.
- No reserve sample retained — 21 CFR 211.170 violation; precludes future investigation.
- Samplers untrained on the specific material's hazard or potency class.
06Cross-industry examples
- Pharma API — 100% identity (NIR or FTIR per container) + composite for full assay/impurity per Ph. Eur./USP monograph.
- Biopharma raw materials — full per-container sampling for cell-culture media due to lot-to-lot performance variability.
- Medical device components — AQL-based attribute sampling per ANSI/ASQ Z1.4 for visual and dimensional checks.
- Food ingredients — composite per truck or per silo with allergen and pathogen screening.
- Cosmetics — identity + microbiological per ISO 17516.
- Cannabis cultivation inputs — pesticide residue and heavy metal sampling per state regulator requirements.
07How V5 Ultimate handles raw material sampling
Frequently asked questions
Q.Is per-container identity always required?+
For drug substances and excipients in the US under 21 CFR 211.84(b)(3), and for APIs under ICH Q7 §7.30 globally, yes. Reduced testing programmes (every other container, etc.) are allowed only after demonstrating supplier reliability through a documented qualification — and even then per-container identity is rarely reduced.
Q.Can the supplier's CoA replace any sampling?+
Under certain conditions per 21 CFR 211.84(d)(2) (supplier qualification programme + periodic re-verification), some conformance testing can be reduced. Identity testing per 211.84(b)(3) cannot be replaced — it is always performed by the manufacturer.
Q.How big should the reserve (retention) sample be?+
21 CFR 211.170(a): at least twice the quantity necessary for all tests required to determine whether the active ingredient meets its specifications. Retained for at least one year past the expiry date of the last drug product into which it was incorporated.
Q.What if a container fails identity?+
That container is rejected; the rest of the lot is investigated. A single container failing identity typically triggers an expanded sampling plan and supplier notification; multiple failures usually mean the entire lot is rejected pending supplier-led investigation.
Q.Can sampling be done in the warehouse?+
Only if the warehouse area meets the cleanroom grade required for the material. For most APIs and excipients this means a dedicated sampling booth, not the open warehouse — taking samples in the open warehouse is a common 483 finding.
Primary sources
Further reading
V5 Ultimate ships with the Raw Material Sampling controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.